Logo image
Ultrasound Sample Entropy Imaging: A New Approach for Evaluating Hepatic Steatosis and Fibrosis
期刊文章   同儕審查

Ultrasound Sample Entropy Imaging: A New Approach for Evaluating Hepatic Steatosis and Fibrosis

Hsien-Jung Chan, Zhuhuang Zhou, Jui Fang, Dar-In Tai, Jeng-Hwei Tseng, Ming-Wei Lai, Bao-Yu Hsieh, Tadashi YamaguchiPo-Hsiang Tsui
IEEE journal of translational engineering in health and medicine, 卷.9, 頁碼.1-12
01/01/2021
PMID: 34786215
Web of Science ID: WOS:000749964200001

摘要

Entropy Fatty liver hepatic steatosis Hospitals Imaging Liver Radio frequency RF signals sample entropy Ultrasonic imaging
Objective: Hepatic steatosis causes nonalcoholic fatty liver disease and may progress to fibrosis. Ultrasound is the first-line approach to examining hepatic steatosis. Fatty droplets in the liver parenchyma alter ultrasound radiofrequency (RF) signal statistical properties. This study proposes using sample entropy, a measure of irregularity in time-series data determined by the dimension m and tolerance r, for ultrasound parametric imaging of hepatic steatosis and fibrosis. Methods: Liver donors and patients were enrolled, and their hepatic fat fraction (HFF) ( n =72), steatosis grade ( n =286), and fibrosis score ( n =65) were measured to verify the results of sample entropy imaging using sliding-window processing of ultrasound RF data. Results: The sample entropy calculated using m = 4 and r =0.1 was highly correlated with the HFF when a small window with a side length of one pulse was used. The areas under the receiver operating characteristic curve for detecting hepatic steatosis that was ≥ mild, ≥ moderate, and ≥ severe were 0.86, 0.90, and 0.88, respectively, and the area was 0.87 for detecting liver fibrosis in individuals with significant steatosis. Discussion/Conclusions: Ultrasound sample entropy imaging enables the identification of time-series patterns in RF signals received from the liver. The algorithmic scheme proposed in this study is compatible with general ultrasound pulse-echo systems, allowing clinical fibrosis risk evaluations of individuals with developing hepatic steatosis.

檔案與連結 (1)

url
https://doi.org/10.1109/JTEHM.2021.3124937檢視
已出版(紀錄版本) 開放

相關連結

詳細資料

Logo image